|
|
DSpace at RU >
Search Results
Results 1-50 of 75.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2011 | XDR tuberculosis | Ingen, J. van; Lange, W.C.M. de; Boeree, M.J.; Iseman, M.D.; Daley, C.L.; Heifets, L.B.; Bottger, E.C.; Soolingen, D. van |
| | 2011 | High-dose rifampicin: how do we proceed? | Boeree, M.J.; Plemper van Balen, G.; Aarnoutse, R. |
| | 2011 | Global clinical trials for the treatment of TB with thioridazine | Boeree, M.J. |
| | 2011 | Xpert MTB/RIF(R), a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis | Bowles, E.C.; Freyee, B.; van Ingen, J.; Mulder, B.; Boeree, M.J.; van Soolingen, D. |
| | 2011 | Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge | Ingen, J. van; Aarnoutse, R.E.; Vries, G. de; Boeree, M.J.; Soolingen, D. van |
| | 2011 | SNP/RD Typing of Mycobacterium tuberculosis Beijing Strains Reveals Local and Worldwide Disseminated Clonal Complexes. | Schurch, A.C.; Kremer, K.; Hendriks, A.C.; Freyee, B.; McEvoy, C.R.; Crevel, R. van; Boeree, M.J.; Helden, P. van; Warren, R.M.; Siezen, R.J.; Soolingen, D. van |
| | 2011 | Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment? | Ingen, J. van; Aarnoutse, R.E.; Donald, P.R.; Diacon, A.H.; Dawson, R.; Plemper van Balen, G.; Gillespie, S.H.; Boeree, M.J. |
| | 2011 | The complexity of the adherence-response relationship in tuberculosis treatment: why are we still in the dark and how can we get out? | Boogaard, J. van den; Boeree, M.J.; Kibiki, G.S.; Aarnoutse, R.E. |
| | 2011 | Nontuberculous mycobacteria in respiratory tract infections, eastern Asia | Simons, S.O.; Ingen, J. van; Hsueh, P.R.; Hung, N. Van; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2011 | Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosis. | Schurch, A.C.; Kremer, K.; Kiers, A.; Boeree, M.J.; Siezen, R.J.; Soolingen, D. van |
| | 2011 | Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007 | Majoor, C.J.; Magis-Escurra Ibanez, C.; Ingen, J. van; Boeree, M.J.; Soolingen, D. van |
| | 2011 | Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species | Ingen, J. van; Tortoli, E.; Selvarangan, R.; Coyle, M.B.; Crump, J.A.; Morrissey, A.B.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2011 | Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotype. | Schurch, A.C.; Kremer, K.; Warren, R.M.; Hung, N.V.; Zhao, Y.; Wan, K.; Boeree, M.J.; Siezen, R.J.; Smith, N.H.; Soolingen, D. van |
| | 2011 | Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania | Boogaard, J. van den; Semvua, H.H.; Ingen, J. van; Mwaigwisya, S.; Laan, T. van der; Soolingen, D. van; Kibiki, G.S.; Boeree, M.J.; Aarnoutse, R.E. |
| | 2011 | Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study | Boogaard, J. van den; Lyimo, R.A.; Boeree, M.J.; Kibiki, G.S.; Aarnoutse, R.E. |
 | 2010 | Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! | Amaral, L.; Boeree, M.J.; Gillespie, S.H.; Udwadia, Z.F.; Soolingen, D. van |
| | 2010 | Disseminated Mycobacterium avium subsp. avium infection in a cat, the Netherlands. | Groot, P.H.; Ingen, J. van; Zwaan, R. de; Mulder, A.; Boeree, M.J.; Soolingen, D. van |
 | 2010 | Otomastoiditis caused by Mycobacterium abscessus, The Netherlands. | Ingen, J. van; Looijmans, F.; Mirck, P.; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | Re-analysis of 178 previously unidentifiable Mycobacterium isolates in the Netherlands in 1999-2007. | Ingen, J. van; Zwaan, R. de; Enaimi, M.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | Assessment of antibacterial sale by using the Anatomic Therapeutic Chemical classification and defined daily dose methodology in Moshi Municipality, Northern Tanzania. | Boogaard, J. van den; Semvua, H.H.; Boeree, M.J.; Aarnoutse, R.E.; Kibiki, G.S. |
| | 2010 | High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster. | Schurch, A.C.; Kremer, K.; Daviena, O.; Kiers, A.; Boeree, M.J.; Siezen, R.J.; Soolingen, D. van |
| | 2010 | Antituberculosis drug-induced hepatotoxicity is uncommon in Tanzanian hospitalized pulmonary TB patients. | Tostmann, A.; Boogaard, J. van den; Semvua, H.; Kisonga, R.; Kibiki, G.S.; Aarnoutse, R.E.; Boeree, M.J. |
| | 2010 | Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells. | Tostmann, A.; Aarnoutse, R.E.; Peters, W.H.M.; Richard, P.N.; Boeree, M.J. |
| | 2010 | Isolation of mycobacteria other than Mycobacterium avium from porcine lymph nodes. | Ingen, J. van; Wisselink, H.J.; Solt-Smits, C.B. van; Boeree, M.J.; Soolingen, D. van |
| | 2010 | The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale. | Schurch, A.C.; Kremer, K.; Kiers, A.; Daviena, O.; Boeree, M.J.; Siezen, R.J.; Smith, N.H.; Soolingen, D. van |
| | 2010 | The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. | Soolingen, D. van; Hernandez-Pando, R.; Orozco, H.; Aguilar, D.; Magis-Escurra Ibanez, C.; Amaral, L.; Ingen, J. van; Boeree, M.J. |
| | 2010 | Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment. | Boogaard, J. van den; Semvua, H.H.; Boeree, M.J.; Aarnoutse, R.E.; Kibiki, G.S. |
| | 2010 | Surgical treatment of non-tuberculous mycobacterial lung disease: strike in time. | Ingen, J. van; Verhagen, A.F.T.M.; Dekhuijzen, P.N.R.; Soolingen, D. van; Magis-Escurra Ibanez, C.; Boeree, M.J.; Lange, W.C.M. de |
| | 2010 | In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. | Ingen, J. van; Laan, T. van der; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. | Ingen, J. van; Hoefsloot, W.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | Nontuberculeuze mycobacteriën : klinisch relevant | Ingen, J. van; Hoefsloot, W.; Lange, W.C.M. de; Magis-Escurra Ibanez, C.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. | Tostmann, A.; Wielders, J.P.; Kibiki, G.S.; Verhoef, H.; Boeree, M.J.; Ven, A.J.A.M. van der |
| | 2010 | Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates. | Ingen, J. van; Simons, S.O.; Zwaan, R. de; Laan, T. van der; Kamst-van Agterveld, M.; Boeree, M.J.; Soolingen, D. van |
| | 2010 | Childhood tuberculosis in the Kilimanjaro region: lessons from and for the TB programme. | Mtabho, C.M.; Irongo, C.F.; Boeree, M.J.; Aarnoutse, R.E.; Kibiki, G.S. |
| | 2009 | In vitro activity of thioridazine against mycobacteria. | Ingen, J. van; Laan, T. van der; Amaral, L.; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van |
| | 2009 | New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. | Boogaard, J. van den; Kibiki, G.S.; Kisanga, E.R.; Boeree, M.J.; Aarnoutse, R.E. |
| | 2009 | Clinical relevance of nontuberculous Mycobacteria, Oman. | Al-Mahruqi, S.H.; Ingen, J. van; Al-Busaidy, S.; Boeree, M.J.; Al-Zadjali, S.; Patel, A.; Dekhuijzen, P.N.R.; Soolingen, D. van |
| | 2009 | Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. | Ingen, J. van; Zwaan, R. de; Dekhuijzen, R.; Boeree, M.J.; Soolingen, D. van |
| | 2009 | Hydrazine-induced liver toxicity is enhanced by glutathione depletion but is not mediated by oxidative stress in HepG2 cells. | Olthof, E.; Tostmann, A.; Peters, W.H.M.; Schaap-Roelofs, H.M.J.; Wagener, F.A.D.T.G.; Scharstuhl, A.; Dekhuijzen, P.N.R.; Boeree, M.J. |
| | 2009 | Clinical experience with the combined use of lopinavir/ritonavir and rifampicin. | L'homme, R.F.A.; Nijland, H.M.J.; Gras, L.; Aarnoutse, R.E.; Crevel, R. van; Boeree, M.J.; Brinkman, K.; Prins, J.M.; Juttmann, J.R.; Burger, D.M. |
| | 2009 | Mycobacterium riyadhense sp. nov., a non-tuberculous species identified as Mycobacterium tuberculosis complex by a commercial line-probe assay. | Ingen, J. van; Al-Hajoj, S.A.; Boeree, M.J.; Al-Rabiah, F.; Enaimi, M.; Zwaan, R. de; Tortoli, E.; Dekhuijzen, R.; Soolingen, D. van |
| | 2009 | Invasive disease caused by nontuberculous mycobacteria, Tanzania. | Crump, J.A.; Ingen, J. van; Morrissey, A.B.; Boeree, M.J.; Mavura, D.R.; Swai, B.; Thielman, N.M.; Bartlett, J.A.; Grossman, H.; Maro, V.P.; Soolingen, D. van |
| | 2009 | SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB). | Martins, M.; Viveiros, M.; Ramos, J.; Couto, I.; Molnar, J.; Boeree, M.J.; Amaral, L. |
| | 2009 | Proposal to elevate Mycobacterium avium complex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov. | Ingen, J. van; Boeree, M.J.; Kosters, K.; Wieland, A.; Tortoli, E.; Dekhuijzen, P.N.R.; Soolingen, D. van |
| | 2009 | Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients. | Ingen, J. van; Boeree, M.J.; Lange, W.C.M. de; Haas, P.E. de; Zanden, A.G. van der; Mijs, W.; Rigouts, L.; Dekhuijzen, P.N.R.; Soolingen, D. van |
| | 2009 | Mycobacterium mantenii sp. nov., a pathogenic, slowly growing, scotochromogenic species. | Ingen, J. van; Lindeboom, J.A.; Hartwig, N.G.; Zwaan, R. de; Tortoli, E.; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2009 | Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans. | Ingen, J. van; Boeree, M.J.; Dekhuijzen, P.N.R.; Soolingen, D. van |
| | 2009 | Clinical relevance of Mycobacterium malmoense isolation in The Netherlands. | Hoefsloot, W.; Ingen, J. van; Lange, W.C.M. de; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2009 | Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. | Ingen, J. van; Zwaan, R. de; Dekhuijzen, P.N.R.; Boeree, M.J.; Soolingen, D. van |
| | 2009 | Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region. | Boogaard, J. van den; Lyimo, R.; Irongo, C.F.; Boeree, M.J.; Schaalma, H.; Aarnoutse, R.E.; Kibiki, G.S. |
1
2
next
|
